AVGO · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $63.89B | $51.57B | $35.82B | $33.20B | $27.45B | $23.89B | $22.60B | $20.85B |
| Cost of Revenue | $20.59B | $19.07B | $11.13B | $11.11B | $10.61B | $10.37B | $10.11B | $10.12B |
| Gross Profit | $43.29B | $32.51B | $24.69B | $22.09B | $16.84B | $13.52B | $12.48B | $10.73B |
| Research & Development | $10.98B | $9.31B | $5.25B | $4.92B | $4.85B | $4.97B | $4.70B | $3.77B |
| Selling, General & Administrative | $4.21B | $4.96B | $1.59B | $1.38B | $1.35B | $1.94B | $1.71B | $1.06B |
| Operating Expenses | $17.81B | $19.05B | $8.48B | $7.87B | $8.32B | $9.50B | $9.04B | $5.60B |
| Operating Income | $25.48B | $13.46B | $16.21B | $14.22B | $8.52B | $4.01B | $3.44B | $5.13B |
| Interest Expense | — | $3.95B | $1.62B | $1.74B | $1.89B | $1.78B | $1.44B | $628.00M |
| Other Income / (Expense) | $455.00M | $406.00M | $512.00M | -$54.00M | $131.00M | $206.00M | $226.00M | $144.00M |
| Income Before Taxes | $22.73B | $9.92B | $15.10B | $12.43B | $6.76B | $2.44B | $2.23B | $4.54B |
| Provision for Income Taxes | -$397.00M | $3.75B | $1.01B | $939.00M | $29.00M | -$518.00M | -$510.00M | -$8.08B |
| Net Income | $23.13B | $5.89B | $14.08B | $11.49B | $6.74B | $2.96B | $2.72B | $12.26B |
| Basic EPS | $4.91 | $1.27 | $3.39 | $2.74 | $15.70 | $6.62 | $6.77 | $29.33 |
| Diluted EPS | $4.77 | $1.23 | $3.30 | $2.65 | $15.00 | $6.33 | $6.43 | $28.44 |
| Basic Shares Outstanding | 4.71B | 4.62B | 4.15B | 4.09B | 410.00M | 402.00M | 398.00M | 418.00M |
| Diluted Shares Outstanding | 4.85B | 4.78B | 4.27B | 4.23B | 429.00M | 421.00M | 419.00M | 431.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Oct 2026 | $10.24 | $9.71 | $12.39 | 13 | ↑1 ↓0 |
| Oct 2027 | $17.53 | $14.56 | $20.69 | 13 | ↑1 ↓0 |
| Oct 2028 | $21.28 | $20.76 | $21.80 | 2 | ↑0 ↓0 |